 |
|
|
REFERENCES
1.
Rhoades RA, Tanner GA: Medical Physiology. Boston,
Little, Brown, 1995, pp 448–449.
2.
Coran AG: Perioperative care of the pediatric patient.
Surg Ann 23(Pt 1):31, 1991.
3.
Haynes MA, Goldenberg IS: Renal effects of anesthesia
and operation mediated by endocrines. Anesthesiology 24:487, 1963.
4.
Imai Y, Abe K, Seino M: Attenuation of pressor
responses to norepinephrine and pitressin and potentiation of pressor response to
angiotensin II by captopril in human subjects. Hypertension 4:444, 1982.
5.
Peach M: Renin-angiotensin system: Biochemistry
and mechanisms of action. Physiol Rev 57:313, 1977.
6.
Millar J, Leckie B, Semple P: Different responses
of active and inactive plasma renin to various stimuli. Clin Sci Mol Med 55:155s,
1978.
7.
Barajas L, Powers K: The structure of the juxtaglomerular
apparatus (JGA) and the control of renin secretion: An update. J Hypertens 2:3,
1984.
8.
Oelkers W, Blumel A, Schoneshofer M: Effects of
ethinyl estradiol on the renin-angiotensin system and on plasma transcortin in women
and men. J Clin Endocrinol Metab 43:1036, 1976.
9.
Herrmann H, Dzau V: The feedback regulation of
angiotensinogen production by components of the renin-angiotensin system. Circ Res
52:328, 1983.
10.
Clauser E, Bouhnik J, Coezzy E, et al: Synthesis
and release of immunoreactive angiotensinogen by rat liver slices. Endocrinology
112:1188, 1983.
11.
Bouhnik J, Galen F, Clauser E, et al: The renin-angiotensin
system in thyroidectomized rats. Endocrinology 108:647, 1981.
12.
Campbell D: The site of angiotensin production.
J Hypertens 3:199, 1985.
13.
Ganong W: The brain renin-angiotensin system.
Annu Rev Physiol 46:17, 1984.
14.
Reid I: The renin-angiotensin system and body
function. Arch Intern Med 145:1475, 1985.
15.
Reid I: Actions of angiotensin II on the brain:
Mechanisms and physiologic role. Am J Physiol 246:F533, 1984.
16.
Re R, Novelline R, Escourrou M, et al: Inhibition
of angiotensin-converting enzyme for diagnosis of renal artery stenosis. N Engl
J Med 298:582, 1978.
17.
Haber E: The role of renin in normal and pathological
cardiovascular hemostasis. Circulation 54:849, 1976.
18.
Kost C: Effect of angiotensin II on plasma adenosine
concentrations in the rat. J Cardiovasc Pharmacol 17:838, 1991.
19.
Ferrario C, Santos R, Brosnihan K, et al: A hypothesis
regarding the function of angiotensin peptides. Clin Exp Hypertens 10A:107, 1988.
20.
Goodfriend T, Peach M: Angiotensin III (DES-aspartic
acid-1)-angiotensin II: Evidence and speculation for its role as an important agonist
in the renin-angiotensin system. Circ Res 36:38, 1975.
21.
Knight PR, Lane GA, Hensinger RN, et al: Catecholamine
and renin-angiotensin response during hypotensive anesthesia induced by sodium nitroprusside
or trimethaphan camsylate. Anesthesiology 55:277, 1981.
22.
Zubrow AB, Daniel SS, Stark RI, et al: Plasma
renin, catecholamine, and vasopressin during nitroprusside-induced hypotension in
ewes. Anesthesiology 58:245, 1983.
23.
Marshal WK, Bedford RF, Arnold WP, et al: Effects
of propranolol on the cardiovascular and renin-angiotensin systems during hypotension
produced by sodium nitroprusside in humans. Anesthesiology 55:277, 1981.
24.
Agre P: Aquaporin water channels in kidney. J
Am Soc Nephrol 11:764, 2000.
25.
Nielsen S, Kwon TH, Christensen BM, et al: Physiology
and pathophysiology of renal aquaporins. J Am Soc Nephrol 19:647, 1999.
26.
Jensen V: The TURP syndrome. Can J Anaesth 38:90,
1991.
27.
Moses AM, Blumenthal SA, Streeten DH: Drugs and
water metabolism. In Arieff AI, Defronzo FA (eds):
Fluid, Electrolyte and Acid-Base Disorders, vol 1. New York, Churchill Livingstone,
1985, p 1145.
28.
Andreoli TE, Carpenter CC, Plum F, et al (eds):
Cecil Essentials of Medicine. Philadelphia, WB Saunders, 1986, pp 195–196.
29.
Zaloga GP, Prough DS: Fluids and electrolytes.
In Barash PG, Cullen BF, Stoelting RK (eds): Clinical
Anesthesia, 2nd ed. Philadelphia, JB Lippincott, 1992, pp 214–236.
30.
Gravenstein D: Transurethral resection of prostate
(TURP) syndrome: A review of the pathology and management. Anesth Analg 84:438,
1997.
31.
Ayus JC, Wheeler J, Arieff AI: Postoperative hyponatremic
encephalopathy in menstruant women. Ann Intern Med 117:891, 1992.
32.
Fraser CL, Sarnacki P: Na+
/K+
ATPase pump function in male rat brain synaptosomes is different from that of females.
Am J Physiol 257:E284, 1989.
33.
Black RM: Disorders of serum sodium and serum
potassium. In Rippe JM, Irwin RS, Alpert JS, et
al (eds): Intensive Care Medicine. Boston, Little, Brown, 1985.
34.
Sarnaik AP, Meert K, Hackbarth R, et al: Management
of hyponatremic seizures in children with hypertonic saline: A safe and effective
strategy. Crit Care Med 19:758, 1991.
35.
Oh M, Carrol H: Disorders of sodium metabolism:
Hypernatremia and hyponatremia. Crit Care Med 20:94, 1992.
36.
Perez GO, Oster JR, Robertson GL: Severe hypernatremia
with impaired thirst. Am J Nephrol 9:421, 1989.
37.
Tanifuji Y, Eger EI: Brain sodium, potassium and
osmolarity: Effects on anesthetic requirement. Anesth Analg 57:404, 1978.
38.
Illner HP, Cunningham JN, Shires GT: Red blood
cell sodium content and permeability changes in hemorrhagic shock. Am J Surg 143:349,
1982.
39.
Coran AG: Perioperative care of the pediatric
patient. Surg Ann 23(Pt 1):31, 1991.
40.
Rosa RM, Silva P, Young JB, et al: Adrenergic
modulation of extrarenal potassium disposal. N Engl J Med 302:431, 1980.
41.
Brown MJ, Brown DL, Murphy MB: Hypokalemia from
β2 receptor stimulation by circulating epinephrine. N Engl J Med 309:1414,
1983.
42.
Hurlbert BJ, Edelman JD, David K: Serum potassium
levels during and after terbutaline. Anesth Analg 60:723, 1981.
43.
Vincent HH, Boomsma F, Man in't Veld AJ, et al:
Effects of selective and nonselective beta agonists on plasma potassium and norepinephrine.
J Cardiovasc Pharmacol 6:107, 1984.
44.
Papademetrious V, Fletcher R, Khatri IM, et al:
Diuretic-induced hypokalemia in uncomplicated systemic hypertension: Effect of
plasma potassium correction on cardiac arrhythmias. Am J Cardiol 52:1017, 1983.
45.
Papademetrious V, Burris J, Kukish SIM, et al:
Effectiveness of potassium chloride or triamterene in thiazide hypokalemia. Arch
Intern Med 145:1986, 1985.
46.
DeFronzo RA: Intravenous potassium chloride therapy.
JAMA 245:2446, 1981.
47.
Solomon RJ, Katz JD: Disturbances of potassium
homeostasis. In Stoelting RK (ed): Advances in
Anesthesia, vol 3. Chicago, Year Book Medical Publishers, 1986.
48.
Surawicz B: Relationship between electrocardiogram
and electrolytes. Am Heart J 73:814, 1967.
49.
Allon M, Takeshian A, Shanklin N: Effect of insulin-plus-glucose
infusion with or without epinephrine or fasting hyperkalemia. Kidney Int 43:212,
1993.
50.
Holick MF, Krane SM, Potts JT: Calcium, phosphorus,
and bone metabolism: Calcium-regulating hormones. In
Isselbacher KJ, Braunwald E, Wilson JD, et al (eds): Harrison's Principles of Internal
Medicine, 13th ed. Boston, McGraw-Hill, 1994, p 2139.
51.
Zaloga GP, Chernow B: Hypocalcemia in critical
illness. JAMA 256:1924, 1986.
52.
Harris MNE, Crowther A, Jupp RA, et al: Magnesium
and coronary revascularization. Br J Anesth 60:779, 1988.
53.
Agus ZA, Wasserstein A, Goldfarb S: Disorders
of calcium and magnesium homeostasis. Am J Med 72:473, 1982.
54.
James MFM: Clinical use of magnesium infusions
in anesthesia. Anesth Analg 74:129, 1992.
55.
Ghoneim MM, Long JP: The interaction between magnesium
and other neuromuscular blocking agents. Anesthesiology 32:23, 1970.
56.
Cross HS, Debiec H, Peterlik M: Mechanism and
regulation of intestinal phosphate reabsorption. Miner Electrolyte Metab 16:115,
1990.
57.
Rhoades RA, Tanner GA: Medical Physiology. Boston,
Little, Brown, 1995, pp 458.
58.
Gray RW, Wilz DR, Calda AE, et al: The importance
of phosphate in regulating plasma 1,25(OH)2
vitamin D levels in humans,
studies in healthy subjects, in calcium-stone formers and in patients with primary
hyperparathyroidism. J Clin Endocrinol Metab 45:299, 1977.
59.
Potts JT: Diseases of the parathyroid gland and
other hyperand hypocalcemic disorders. In Isselbacher
KJ, Braunwald E, Wilson JD, et al (eds): Harrison's Principles of Internal Medicine,
13th ed. Boston, McGraw-Hill, 1994, p 2170.
60.
Levinsky NG: Acidosis and alkalosis. In
Isselbacher KJ, Braunwald E, Wilson JD, et al (eds): Harrison's Principles of Internal
Medicine, 13th ed. McGraw-Hill, Inc., 1994, p 255.
61.
Drummond JC, Moore SS: The influence of dextrose
administration on neurologic outcome after temporary spinal cord ischemia in the
rabbit. Anesthesiology 70:64, 1989.
62.
Sieber FE, Traystman RJ: Special issues: Glucose
and the brain. Crit Care Med 20:104, 1992.
63.
Stagnaro-Green A: Perioperative glucose control:
Does it really matter? Mt Sinai J Med 58:299, 1991.
64.
McMurry JF Jr: Wound healing with diabetes mellitus.
Better glucose control for better wound healing in diabetes. Surg Clin North Am
64:769, 1984.
65.
Bagdale JD, Nielson KL, Bulger JF: Reversible
abnormalities in phagocytic function in poorly controlled diabetic patients. Am
J Med Sci 263:451, 1972.
66.
Welborn LG, McGill WA, Hannallah RS, et al: Perioperative
blood glucose concentrations in pediatric outpatients. Anesthesiology 65:543, 1986.
67.
Welborn LG, McGill WA, Hannallah RS, et al: Glucose
concentrations for routine intravenous infusion in pediatric outpatient surgery.
Anesthesiology 67:427, 1987.
68.
Degoute CS, Ray MJ, Manchon M, et al: Intraoperative
glucose infusion and blood lactate: Endocrine and metabolic relationships during
abdominal aortic surgery. Anesthesiology 71:355, 1989.
69.
The Carter Center of Emory University: Closing
the gap: The problem of diabetes mellitus in the United States. Diabetes Care 8:391,
1985.
70.
Nesmeth J: Type 2 diabetes in children and adolescents.
Pediatr Rev 105:671, 2000.
71.
Foster DW: Endocrinology and metabolism. In
Wilson JD, Braunwald E, Fauci AS, et al (eds): Harrison's Principles of Internal
Medicine, 12th ed. New York, McGraw-Hill, 1991, p 1743.
72.
Engelgau MM, Herman WH, Smith PJ, et al: The epidemiology
of diabetes and pregnancy in the U.S., 1988. Diabetes Care 18:1029, 1995.
73.
Stewart WJ, McSweeney SM, Kellet MA, et al: Increased
risk of severe protamine reactions in NPH insulin-dependent diabetics undergoing
cardiac catheterization. Circulation 70:788, 1984.
74.
Humalog (insulin lispro) package insert. Indianapolis,
IN, Eli Lilly, 2001.
75.
Kucera ML, Graham JP: Insulin lispro, a new insulin
analog. Pharmacotherapy 18:526, 1998.
76.
Dimarchi RD, Chance RE, Lon HB, et al: Preparation
of an insulin with improved pharmacokinetics relative to human insulin through consideration
of structure homology with insulin like growth factor 1. Horm Res 41(Suppl 2):93,
1994.
77.
Howey DC, Bowsher RR, Brunelle RL, Woodworth JR:
Lys(B28) Pro(B29) human insulin: A rapidly absorbed analog of human insulin. Diabetes
43:396, 1994.
78.
Ciszak E, Beals JM, Frank BH, et al: Role of C-terminal
B-chain residues in insulin assembly: The structure of Hexameric Lys(B28) Pro(B29)
human insulin. Structure 3:615, 1995.
79.
Lantus (insulin glargine) package insert. Kansas
City, MO, Aventis Pharmaceuticals, April 2000.
80.
Heinemann L, Linkeschova R, Rave K, et al: Time
action profile of the long-acting insulin analog insulin glargine (HOE 901) in comparison
with those of NPH insulin and placebo. Diabetes Care 23:644, 2000.
81.
Madsen H, Ditzel J: Changes in red blood cell
oxygen transport in diabetic pregnancy. Am J Obstet Gynecol 143:421, 1982.
82.
Kitamura A, Hoshino T: Patients with diabetic
neuropathy are at risk of a greater intraoperative reduction in core temperature.
Anesthesiology 92:1311, 2000.
83.
Tsueda K, Huang KC, Dumond SW, et al: Cardiac
sympathetic tone in anaesthetized diabetics. Can J Anaesth 38:20, 1991.
84.
Kannel W, McGee D: Diabetes and cardiovascular
disease: The Framingham Study. JAMA 241:2035, 1979.
85.
Haffner SM, Lehto S, Ronnemaa T, et al: Mortality
from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects
with and without prior myocardial infarction. N Engl J Med 339:229, 1998.
86.
Schaade DS: Surgery and diabetes. Med Clin North
Am 72:1531, 1988.
87.
Gavin LA: Management of diabetes mellitus during
surgery. West J Med 151:525, 1989.
88.
Reissel E, Orko R, Maunuksela E, et al: Predictability
of difficult laryngoscopy in patients with long-term diabetes mellitus. Anaesthesia
43:1024, 1990.
89.
Hogan K, Rusty D, Springman SR: Difficult laryngoscopy
and diabetes mellitus. Anesth Analg 67:1162, 1988.
90.
Davidson MB, Schriger DC, Peters AL, et al: A
clinical approach for the diagnosis of diabetes mellitus: An analysis using glycosylated
hemoglobin levels. JAMA 276:1246, 1996.
91.
Nathan DM: Hemoglobin A1c
: Infatuation
or the real thing? N Engl J Med 323:1062, 1990.
92.
American Hospital Formulary Service: Miscellaneous
antidiabetic agents. Bethesda, MD, ASHP, 2000, 68.20.92 3032–41.
93.
Glucophage R (metformin) product information.
Princeton, NJ, Bristol-Myers-Squibb, October 2000.
94.
Watson BG, Pay DA, Williamson M, et al: Practical
closed-loop insulin infusion. Life Support Syst 3(Suppl 1):519, 1985.
95.
Hirsch IB, Magill JB, Cryer PE, et al: Perioperative
management of surgical patients with diabetes mellitus. Anesthesiology 74:346, 1991.
96.
Nutt LK, O'Neil RG: Effect of elevated glucose
on endothelin-induced store-operated and non-store-operated calcium influx in renal
mesangial cells. J Am Soc Nephrol 11:1225, 2000.
97.
Marhoffer W, Stein M, Maeser D, et al: Impairment
of PMN leukocyte function and metabolic control of diabetes. Diabetes Care 15:256,
1992.
98.
Furnary AP, Zerr KJ, Grunkemeier GL, Starr A:
Continuous intravenous insulin infusion reduces the incidence of deep sternal wound
infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg
67:352, 1999.
99.
Rassias AJ, Marrin CA, Arruda J, et al: Insulin
infusion improves neutrophil function in diabetic cardiac surgery patients. Anesth
Analg 88:1011, 1999.
100.
Khaodhiar L, McCowen K, Bistrian B: Perioperative
hyperglycemia, infections and risk. Curr Opin Clin Nutr Metab Care 2:79, 1999.
101.
Boyle PJ, Schwartz NS, Shah SD, et al: Plasma
glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly
controlled diabetes and in nondiabetics. N Engl J Med 318:1487, 1988.
102.
Wasserstrum N: Issues in fluid management during
labor: General considerations. Clin Obstet Gynecol 35:505, 1992.
103.
Wallace EL, Surgenor DM, Hao HS, et al: Collection
and transfusion of blood and blood components in the United States, 1989. Transfusion
33:139, 1993.
104.
Shires T, Cohn D, Carrico J, et al: Fluid therapy
in hemorrhagic shock. Arch Surg 88:688, 1964.
105.
Shoemaker WC, Appel PL, Kram HB, et al: Prospective
trial of supranormal values of survivors as therapeutic goals in high risk surgical
patients. Chest 94:1176, 1988.
106.
Hayes, MA, Timmins AC, Yau E, et al: Elevation
of systemic oxygen delivery in the treatment of critically ill patients. N Engl
J Med 330:1712, 1994.
107.
Gattinoni L, Brazzi L, Pelosi P, et al: A trial
of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 333:1025,
1995.
108.
Boyd O, Grounds M, Bennett ED: A randomized clinical
trial of the effect of deliberate peri-operative increase of oxygen delivery on mortality
in high risk surgical patients. JAMA 270:2699, 1993.
109.
Sinclair S, James S, Singer M: Intraoperative
intravascular volume optimisation and length of hospital stay after repair of proximal
femoral fracture; randomised control trial. BMJ 315:909, 1997.
110.
Lobo SMA, Salgado PF, Castillo VGT, et al: Effects
of maximizing oxygen delivery on morbidity and mortality in high risk surgical patients.
Crit Care Med 28:3396, 2000.
111.
Schakford SR, Fortlage DA, Peters RM, et al:
Serum osmolar and electrolyte changes associated with large infusions of hypertonic
sodium lactate for intravascular volume expansion of patients undergoing aortic reconstruction.
Surg Gynecol Obstet 164:127, 1987.
112.
Rocha e Silva M, Velasco IT, Portirio MMF: Hypertonic
saline resuscitation: Saturated salt-dextran solutions are equally effective, but
induce hemolysis in dogs. Crit Care Med 18:203, 1990.
113.
Velasco IT, Pontieri V, Rocha e Silva M, et al:
Hyperosmotic NaCl and severe hemorrhagic shock. Am J Physiol 239:H664-H673, 1980.
114.
Bunn F, Roberts I, Tasker R, et al: Hypertonic
versus isotonic crystalloid for fluid resuscitation in critically ill patients.
Cochrane Database Syst Rev 4:CD002045, 2000; update in 1:CD002045, 2002.
115.
Kreimeier U, Bruckner UB, Niemczyk S, et al:
Hyperosmostic saline dextran for resuscitation from traumatic-hemorrhagic hypotension:
Effect on regional blood flow. Circ Shock 32:83, 1990.
116.
Leppaniemi A, Soltero R, Burris D, et al: Early
resuscitations with low-volume polyDC1Hb is effective in the treatment of shock induced
by penetrating vascular injury. J Trauma 40:242, 1996.
117.
Moss GS, Gould SA: Plasma expanders: An update.
Am J Surg 155:425, 1988.
118.
Velanovich V: Crystalloid versus colloid fluid
resuscitation: A meta-analysis of mortality. Surgery 105:65, 1989.
119.
Kaufman CR: Usefulness of thromboelastography
in assessment of trauma patient coagulation. J Trauma 42:716, 1997.
120.
Martin G, Bennett-Guerrero E, Wakeling H, et al:
A prospective, randomized comparison of thromboelastographic coagulation profile
in patients receiving lactated Ringer's solution, 6% hetastarch in a balanced-saline
vehicle, or 6% hetastarch in saline during major surgery. J Cardiothorac Vasc Anesth
16:441, 2002.
121.
Tuullis JL: Albumin. Background and uses. JAMA
237:355, 1977.
122.
Ibister JP, Fisher MM: Adverse effects of plasma
volume expanders. Anaesth Intensive Care 8:145, 1980.
123.
Mangar D, Gerson JI, Constantine RM, et al: Pulmonary
edema and coagulopathy due to hyskon (32% dextran-70) administration. Anesth Analg
68:686, 1989.
124.
Straus RG: Volume replacement and coagulation:
A comparative review. J Cardiothorac Vasc Anesth 2(Suppl 1):24, 1988.
125.
Spence RK, McCoy S, Costablie J, et al: Fluosol
DA-20 in the treatment of severe anemia: Randomized, controlled study of 46 patients.
Crit Care Med 18:1227, 1990.
126.
Leone BJ, Spahn DR: Anemia, hemodilution, and
oxygen delivery. Anesth Analg 75:651, 1992.
127.
Shires T, Williams J, Brown F: Acute change in
extracellular fluids associated with major surgical procedures. Ann Surg 154:803,
1961.
128.
Roth E, Lax L, Maloney J: Ringer's lactate solution
and extracellular fluid volume in the surgical patient: A critical analysis. Ann
Surg 169:149, 1969.
129.
Prien T, Backhaaus N, Pelster F, et al: Effect
of intraoperative fluid administration and colloid osmotic pressure on the formation
of intestinal edema during gastrointestinal surgery. J Clin Anesth 2:317, 1990.
130.
Schrieer RW: Pathogenesis of sodium and water
retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis
and pregnancy. N Engl J Med 319:1127, 1988.
131.
Epstein M: Atrial natriuretic factor in patients
with liver disease. Am J Nephrol 9:89, 1989.
132.
Salerno F, Badalamenti S, Moser P, et al: Atrial
natriuretic factor in cirrhotic patients with tense ascites. Effect of large-volume
paracentesis. Gastroenterology 98:1063, 1990.
133.
Wisner D, Busche F, Sturm J, et al: Traumatic
shock and head injury: Effects of fluid resuscitation on the brain. J Surg Res
46:49, 1989.
134.
Jackowski A: Disordered sodium and water in neurosurgery.
Br J Neurosurg 6:173, 1992.
135.
Dietsch EA: The management of burns. N Engl
J Med 323:1249, 1990.
136.
Dietsch EA: Burn management. In
Ripe JM, Irwin RS, Alpert JS, et al (eds): Intensive Care medicine, 2nd ed. Boston,
Little, Brown, 1991, p 1507.
137.
Waserstrum N: Issues in fluid management during
labor: Maternal plasma volume status and volume loading. Clin Obstet Gynecol 35:514,
1992.
138.
Gilliland MD, Coates N: Tumescent liposuction
complication by pulmonary edema. Plast Reconstr Surg 99:215, 1997.
139.
Pitman GH: Tumescent liposuction complication
by pulmonary edema. Plast Reconstr Surg 100:1363, 1997.
140.
Rao RB, Ely SF, Hoffman RS: Deaths related to
liposuction. N Engl J Med 340:1471, 1999.
141.
Ostad A, Kageyama N, Moy RL: Tumescent anesthesia
with lidocaine dose of 55 mg/kg is safe for liposuction. 22:921, 1996.
142.
Laffon M, Jayr C, Barbry P, et al: Lidocaine
induces a reversible decrease in alveolar epithelial fluid clearance in rats. Anesthesiology
96:393, 2002.
143.
Coleman W 3rd, Glogau RG, Klein JA, et al: Guidelines
of care for liposuction. J Am Acad Dermatol 45:438, 2001.
